In 2020, right when Jane Baude was starting her Ph.D. research at UC Santa Barbara, she learned that a critical component of ...
News Medical on MSN
Novel antibiotic targets IBD—and AI predicted how it would work before scientists could prove it
Researchers at McMaster University and the Massachusetts Institute of Technology (MIT) have made two scientific breakthroughs ...
GlobalData on MSN
McMaster University and MIT discover new antibiotic for IBD
Discovered at McMaster, the newly identified antibiotic presents a potential new therapy for individuals living with Crohn's ...
Vitamin D significantly affects IBD by influencing severity, inflammation, and patient outcomes. Optimizing vitamin D levels ...
A once-daily pill for ulcerative colitis has delivered strong results in a clinical trial, easing symptoms even in patients ...
Investor's Business Daily on MSN
How BeOne Medicines, An IBD 50 Stock, Is Taking On Big Names In Cancer Treatment
As the former BeiGene gears up to battle AbbVie and J&J, shares of the new BeOne Medicines haven't been this high in four ...
Subcutaneous vedolizumab dose intensification restored steroid-free clinical response in approximately one-third of patients with IBD.
Experts discuss the central role of patient education and the strategic use of topical therapies in managing atopic dermatitis (AD), emphasizing the need for clear communication, age-appropriate ...
Often overlooked in our quest for superfoods, the fibre is having a moment. Nutritionists and chefs are designing diets rich ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback